Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States
- PMID: 30406756
- PMCID: PMC6261794
- DOI: 10.1016/j.annepidem.2018.05.006
Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States
Abstract
Purpose: HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission. Finding a PrEP provider, however, can be a barrier to accessing care. This study explores the distribution of publicly listed PrEP-providing clinics in the United States.
Methods: Data regarding 2094 PrEP-providing clinics come from PrEP Locator, a national database of PrEP-providing clinics. We compared the distribution of these PrEP clinics to the distribution of new HIV diagnoses within various geographical areas and by key populations.
Results: Most (43/50) states had less than one PrEP-providing clinic per 100,000 population. Among states, the median was two clinics per 1000 PrEP-eligible men who have sex with men. Differences between disease burden and service provision were seen for counties with higher proportions of their residents living in poverty, lacking health insurance, identifying as African American, or identifying as Hispanic/Latino. The Southern region accounted for over half of all new HIV diagnoses but only one-quarter of PrEP-providing clinics.
Conclusions: The current number of PrEP-providing clinics is not sufficient to meet needs. In addition, PrEP-providing clinics are unevenly distributed compared to disease burden, with poor coverage in the Southern divisions and areas with higher poverty, uninsured, and larger minority populations. PrEP services should be expanded and targeted to address disparities.
Keywords: HIV; Pre-exposure prophylaxis; Primary prevention.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. MMWR Morbidity and mortality weekly report. 2015;64(46):1291–5. - PubMed
-
- Mera Giler R, Trevor H, Bush S, Rawlings K, McCallister S, editors. Changes in truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States:(2012–2016); 9th International AIDS Society Conference on HIV Science; 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
